Cipla expects elevated capital expenditure on automation to continue for three more years Ruchika Sharma27 Dec 2022 5:31 PM ISTMumbai: Cipla expects elevated capital expenditure on automation to continue for three more years, a senior official has said. The city-headquartered...
NPPA fixes retail price of 10 formulations Roshni Dhar21 Dec 2022 5:43 PM ISTThrough a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed...
Health Bulletin 21/December/2022 Roshni Dhar21 Dec 2022 5:09 PM ISTHere are the top health news for the day:Google will soon help translate doctor's handwritten prescriptionThe giant search engine, Google aims to...
NPPA Fixes Retail Price Of 10 Formulations, Details Susmita Roy20 Dec 2022 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Cipla Gets CDSCO Panel Nod To Manufacture, Market FDC Tamsulosin plus Solifenacin Dr. Divya Colin7 Dec 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Cipla has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Cipla unveils Leuprolide Acetate Injection Depot for advanced prostate cancer in US Ruchika Sharma29 Nov 2022 1:00 PM ISTMumbai: Pharma major Cipla Limited and its wholly owned subsidiary Cipla USA Inc., today announced the launch of Leuprolide Acetate Injection Depot ...
NPPA fixes retail price of 40 Formulation, Details Dr. Divya Colin25 Nov 2022 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Cipla gets USFDA OAI status for Goa facility Ruchika Sharma24 Nov 2022 1:30 PM ISTMumbai: Pharma major Cipla has announced that the company has received a communication from the US Food and Drug Administration (USFDA) that the...
Cipla gets CDSCO Panel nod to manufacture, market COPD drug combination Aerosol for inhalation Susmita Roy23 Nov 2022 6:00 PM ISTNew Delhi: Granting the phase III clinical trial study waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
DoP Directs NPPA to consider Cipla application for retail price fixation of asthma drug combination Farhat Nasim5 Nov 2022 6:00 PM ISTNew Delhi: In a major respite to Cipla Ltd., embroiled in a legal battle for almost three years over the price of an Asthma inhaler drug, the...
Cipla reports bigger-than-expected 11 percent increase in Q2 profit Ruchika Sharma5 Nov 2022 11:15 AM ISTTotal revenue from operations increased 5 percent to 57.59 billion rupees.
Dr Reddy's, Cipla, Aurobindo units recall products in US market Kajal Rajput25 Oct 2022 5:13 PM ISTNew Delhi: Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various...
